Johnson and Johnsons booster slashes Omicron hospitalizations, study shows
A booster dose of Johnson & Johnson's single-dose COVID-19 vaccine was 84% effective at preventing hospitalization in South African healthcare workers who became infected as the Omicron variant spread, researchers said on Thursday.
#JohnsonJohnson #BoosterDose #COVID #Omicron #Coronavirus #Vaccine #News #Reuters
Sign in to join the conversation.
Sign in with Google
Sign in with Google
Latest Videos
Comments